Assoc. Prof. Dr. Nermeen Elbakary | Biochemistry | Best Researcher Award
Associate professor of Biochemistry | Egyptian Atomic Energy Authority | Egypt
Dr. Nermeen Mohamed Sayed Ahmed Badr Elbakary is an accomplished biochemist and associate professor in the Radiation Biology Department at the National Centre for Radiation Research and Technology (NCRRT), Atomic Energy Authority, Cairo, Egypt. With extensive experience in cancer biology, molecular genetics, and radiation effects, she has led numerous investigations on therapeutic resistance, radiotherapy, and the molecular signaling mechanisms of anticancer compounds. Dr. Elbakary is proficient in cutting-edge molecular biology techniques, animal models, and high-throughput sequencing. She is an active member of several professional societies, including the Egyptian Society of Biochemistry and the Japan Radiation Research Society. She has served as a reviewer for high-impact journals such as Scientific Reports, Integrative Cancer Therapies, and Toxicology Reports. Her research is widely recognized for its translational value in cancer therapy and biomarker discovery. Her involvement in scientific conferences and collaborative research networks underscores her dedication to advancing biochemical and radiological sciences.
Professional Profile
Scopus
Orcid
Google Scholar
Education
Dr. Elbakary’s academic journey began with a B.Sc. in Chemistry and Biochemistry from Zagazig University in 2007, followed by a Diploma in Biochemistry in 2008 from the same institution. She pursued pre-master coursework in Biochemistry at Tanta University in 2010. Her Master’s degree in Molecular Cancer Biology was earned at the Genetic Engineering and Biotechnology Research Institute (GEBRI), Al-Sadat City University. She was awarded a Ph.D. in Biochemistry from Ain Shams University in 2017, focusing on molecular mechanisms of radiation and natural compounds in cancer biology. Throughout her education, she complemented her scientific expertise with certifications in TOEFL and ICDL and participated in over 30 specialized training programs, including advanced biostatistics, genomics, research ethics, and proposal writing. Her interdisciplinary training spans classical biochemistry, molecular therapeutics, and modern analytical techniques such as CRISPR, proteomics, and molecular docking, positioning her at the forefront of radiation biology and translational medicine.
Experience
Dr. Elbakary began her research career as an MSc scholar at the Atomic Energy Authority, supported by the Academy of Scientific Research and Technology (ASRT). From 2011 to 2018, she served as a demonstrator of Chemistry at Science Valley Academy. She then progressed through several academic ranks at NCRRT, including Biochemistry Specialist (2012–2014), Assistant Lecturer (2014–2017), Lecturer (2017–2022), and currently as Associate Professor (since 2023). She has mentored multiple Ph.D. and Master’s theses, notably in experimental therapeutics for hepatocellular and colon carcinoma. Dr. Elbakary’s technical proficiencies encompass in vivo cancer models, flow cytometry, Western blotting, ELISA, CRISPR gene editing, and data science using R and SPSS. Her teaching and lab supervision have shaped aspiring biochemists and researchers, while her collaborations with institutions like Cairo University and Al-Azhar University emphasize her leadership in academic research. She is actively involved in scientific outreach and healthcare campaigns, including national screenings and community health programs.
Research Interests
Dr. Elbakary’s research lies at the intersection of cancer biology, radiation therapeutics, and molecular pharmacology. She is particularly interested in how low-dose gamma radiation influences cancer cell pathways, and how natural compounds like resveratrol, ashwagandha, prodigiosin, and fucoxanthin enhance radiosensitivity and inhibit tumor progression. Her expertise spans apoptosis, inflammation, signal transduction, and epigenetic regulation. She has investigated the MAPK/TNF-α/NLRP3, JAK/STAT3, and β-Catenin/NOTCH pathways, as well as the impact of CRISPR-based interventions in oncology. Additionally, she is engaged in bioinformatics, studying transcriptomics, TCGA data, and biomarker validation using tools like GSEA and molecular docking. Dr. Elbakary also delves into nanoparticle-based drug delivery systems and bacterial therapies, aiming to develop safer, more effective anti-cancer treatments. Her multidisciplinary research integrates laboratory experimentation with computational modeling, making significant contributions to translational cancer therapeutics and personalized medicine. Her goal remains clear: advancing cancer treatment strategies that combine precision biology with biotechnological innovation.
Awards
Dr. Elbakary has received multiple recognitions throughout her career. Her early achievements include a prestigious scholarship for her MSc studies from the Academy of Scientific Research and Technology (ASRT). She was awarded the “Scientists for the Next Generation” training program, which provided foundational skills in grant writing, lab safety, and biostatistics. She was a featured guest editor for Archive and Case Report Journal and has served as a reviewer for prominent scientific journals, including Scientific Reports, Biomed Research International, Integrative Cancer Therapies, and Human and Experimental Toxicology. In addition to her academic accolades, Dr. Elbakary has been an invited speaker and attendee at over 40 national and international conferences, including the BGICC, AASD, and SESAME. Her voluntary participation in national health initiatives, such as Egypt’s HCV and non-communicable diseases screening campaigns, underscores her commitment to public health. She is a member of multiple scientific societies, including the Japan Radiation Research Society and WiN Egypt.
Top Noted Publications
Title: Role of bee venom and melittin on restraining angiogenesis and metastasis in Îł-irradiated solid Ehrlich carcinoma-bearing mice
Year: 2020
Cited by: 52
Title: Antitumor and radiosensitizing synergistic effects of apigenin and cryptotanshinone against solid Ehrlich carcinoma in female mice
Year: 2017
Cited by: 33
Title: Gamma radiation-attenuated Toxoplasma gondii provokes apoptosis in Ehrlich ascites carcinoma-bearing mice generating long-lasting immunity
Year: 2020
Cited by: 30
Title: Pomegranate peel extract sensitizes hepatocellular carcinoma cells to ionizing radiation, induces apoptosis and inhibits MAPK, JAK/STAT3, β-catenin/NOTCH, and SOCS3 signaling
Year: 2023
Cited by: 19
Title: Withania somnifera (Ashwagandha) root extract counteracts acute and chronic impact of Îł-radiation on liver and spleen of rats
Year: 2022
Cited by: 18
Title: Pro-apoptotic and anti-neoplastic impact of luteolin on solid Ehrlich carcinoma-bearing mice exposed to gamma radiation
Year: 2020
Cited by: 18
Conclusion